Experimental evidence in breast cancer and other cell lines suggests that steroids and growth factor signaling pathways such as EGF and IGF-1 have synergistic effects in inducing cell proliferation and that cross-talk between these pathways is important in estrogen action [41–45]. The gene discussed is EGF; the disease is breast carcinoma.